Works matching IS 17574676 AND DT 2019 AND VI 11 AND IP 4

Results: 7

Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis.

Published in:

EMBO Molecular Medicine, 2019, v. 11, n. 4, p. N.PAG, doi. 10.15252/emmm.201910360

By:

Di Pasquale, Elisa;
Condorelli, Gianluigi

Publication type:

Article

Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells.

Published in:

EMBO Molecular Medicine, 2019, v. 11, n. 4, p. N.PAG, doi. 10.15252/emmm.201809736

By:

Hamczyk, Magda R;
Villa‐Bellosta, Ricardo;
Quesada, Víctor;
Gonzalo, Pilar;
Vidak, Sandra;
Nevado, Rosa M;
Andrés‐Manzano, María J;
Misteli, Tom;
López‐Otín, Carlos;
Andrés, Vicente

Publication type:

Article

Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma.

Published in:

EMBO Molecular Medicine, 2019, v. 11, n. 4, p. N.PAG, doi. 10.15252/emmm.201708492

By:

Przystal, Justyna Magdalena;
Waramit, Sajee;
Pranjol, Md Zahidul Islam;
Yan, Wenqing;
Chu, Grace;
Chongchai, Aitthiphon;
Samarth, Gargi;
Olaciregui, Nagore Gene;
Tabatabai, Ghazaleh;
Carcaboso, Angel Montero;
Aboagye, Eric Ofori;
Suwan, Keittisak;
Hajitou, Amin

Publication type:

Article

NrCAM is a marker for substrate‐selective activation of ADAM10 in Alzheimer's disease.

Published in:

EMBO Molecular Medicine, 2019, v. 11, n. 4, p. N.PAG, doi. 10.15252/emmm.201809695

By:

Brummer, Tobias;
Müller, Stephan A;
Pan‐Montojo, Francisco;
Yoshida, Fumiaki;
Fellgiebel, Andreas;
Tomita, Taisuke;
Endres, Kristina;
Lichtenthaler, Stefan F

Publication type:

Article

Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments.

Published in:

EMBO Molecular Medicine, 2019, v. 11, n. 4, p. N.PAG, doi. 10.15252/emmm.201809575

By:

Jakobs, Martin;
Fomenko, Anton;
Lozano, Andres M;
Kiening, Karl L

Publication type:

Article

Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth.

Published in:

EMBO Molecular Medicine, 2019, v. 11, n. 4, p. N.PAG, doi. 10.15252/emmm.201809539

By:

Thilakasiri, Pathum;
Huynh, Jennifer;
Poh, Ashleigh R;
Tan, Chin Wee;
Nero, Tracy L;
Tran, Kelly;
Parslow, Adam C;
Afshar‐Sterle, Shoukat;
Baloyan, David;
Hannan, Natalie J;
Buchert, Michael;
Scott, Andrew Mark;
Griffin, Michael DW;
Hollande, Frederic;
Parker, Michael W;
Putoczki, Tracy L;
Ernst, Matthias;
Chand, Ashwini L

Publication type:

Article

ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer.

Published in:

EMBO Molecular Medicine, 2019, v. 11, n. 4, p. N.PAG, doi. 10.15252/emmm.201809976

By:

Saad, Mohamed I;
Alhayyani, Sultan;
McLeod, Louise;
Yu, Liang;
Alanazi, Mohammad;
Deswaerte, Virginie;
Tang, Ke;
Jarde, Thierry;
Smith, Julian A;
Prodanovic, Zdenka;
Tate, Michelle D;
Balic, Jesse J;
Watkins, D Neil;
Cain, Jason E;
Bozinovski, Steven;
Algar, Elizabeth;
Kohmoto, Tomohiro;
Ebi, Hiromichi;
Ferlin, Walter;
Garbers, Christoph

Publication type:

Article